Tvardi Therapeutics Ord Shs
TVRD4.323USD
+0.033+0.78%
Market hours （ET）Quotes delayed by 15 min
--Market Cap
LossP/E TTM
Tvardi Therapeutics Ord Shs Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
7.14M
-65.96%
EPS(YoY)
-46.60
--
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its total revenue reached 7.14M, with a year-on-year change of -65.96%.
What is the Earnings Per Share (EPS) of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its Earnings Per Share (EPS) was -46.595, with a year-on-year change of --.
What is the net income of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its net income was -70.87M, with a year-on-year change of 40.20%.
What is the net margin of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its net profit margin was -992.95%, with a year-on-year change of --.
What is the gross margin of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its gross margin was 91.31%, with a year-on-year change of --.
What is the debt-to-asset ratio of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its Return on Equity (ROE) was -270.01%, with a year-on-year change of --.
What is the Return on Assets (ROA) of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its Return on Assets (ROA) was -83.53%, with a year-on-year change of --.
What is the operating profit of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its operating profit was -52.82M, with a year-on-year change of 56.53%.
What are the current assets of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its current assets were 43.83M, with a year-on-year change of -62.27%.
What are the total assets of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its total assets of Tvardi Therapeutics Ord Shs were 43.83M, with a year-on-year change of -65.17%.
What are the total liabilities of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its total liabilities of Tvardi Therapeutics Ord Shs were 48.42M, with a year-on-year change of -29.58%.
What is the total equity of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its total equity of Tvardi Therapeutics Ord Shs was -4.59M, with a year-on-year change of -108.05%.
What is the net operating income of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its net operating income of Tvardi Therapeutics Ord Shs was -70.87M, with a year-on-year change of 40.20%.
What is the net investment of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its net investment of Tvardi Therapeutics Ord Shs was 48.74M, with a year-on-year change of 12.15%.
What is the net financing of Tvardi Therapeutics Ord Shs?
According to Tvardi Therapeutics Ord Shs's FY2024 earnings report, its net financing of Tvardi Therapeutics Ord Shs was -3.60M, with a year-on-year change of -109.45%.
